Font: Financial Modeling Prep • Jul 31, 2026
TOP Financial Group Limited (NASDAQ: TOP), an online brokerage firm, boasts a market capitalization of approximately $77.55 million. The company's stock currently trades at $2.09 per share. Operating within the competitive financial services sector, TOP Financial Group Limited provides essential brokerage services to its clients.
TOP Financial Group Limited has announced an upcoming 1-for-5 reverse stock split. This strategic action, also known as a share consolidation, means that for every five shares an investor owns, they will be combined into a single share. This process is typically employed to increase the per-share price of a company's stock, often to meet exchange listing requirements or enhance investor perception.
The reverse stock split is scheduled to become effective on August 3, 2026. As highlighted by GlobeNewswire, this significant decision was approved by TOP Financial Group Limited's board of directors. It follows an authorization from shareholders, which was granted during a special meeting held on May 27, 2026.
On the effective date, TOP Financial Group Limited's Class A shares will begin trading on a post-split basis on the Nasdaq. The stock will continue to trade under its existing symbol "TOP". However, for tracking and settlement purposes, the shares will be assigned a new CUSIP number, which will be G989A6110.
|
ADGM§>
Adagio Medical Holdings, Inc.
|
$0.80
73.91%
|
|
TNMG§>
TNL Mediagene
|
$0.48
33.06%
|
|
ENSC§>
Ensysce Biosciences, Inc.
|
$0.38
37.17%
|
|
PLTR§>
Palantir Technologies Inc.
|
$162.66
29.45%
|
|
SXTC§>
China SXT Pharmaceuticals, Inc.
|
$0.12
60.08%
|
|
NVDA§>
NVIDIA Corporation
|
$211.94
2.56%
|
|
QNME§>
Lakeside Holding Limited
|
$0.69
-37.59%
|
|
AMIX§>
Autonomix Medical, Inc.
|
$19.50
434.25%
|
|
INTC§>
Intel Corp.
|
$100.86
10.84%
|
|
VTGN§>
VistaGen Therapeutics, Inc.
|
$0.30
22.45%
|